A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence-Reference-Cited by-同舟云学术

A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence

Published:2007-10-27 Issue:1 Volume:43 Page:53-61
ISSN:1464-3502
Container-title:Alcohol and Alcoholism
language:en
Short-container-title:

Author:

Laaksonen E.,Koski-Jännes A.,Salaspuro M.,Ahtinen H.,Alho Hannu

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/alcalc/article-pdf/43/1/53/17047136/agm136.pdf

Reference35 articles.

1. Pharmacologic approaches to the management of alcoholism;Anton;Journal of Clinical Psychiatry,2001

2. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial;Anton;American Journal of Psychiatry,1999

3. Alcoholism treatment by DIS and community reinforcement therapy;Azrin;Journal of Behavior Therapy and Experimental Psychiatry,1982

4. Treatment of alcohol abuse: an evidence-based review;Berglund;Alcoholism, Clinical and Experimental Research,2003

5. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review;Bouza;Addiction,2004

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alcoholic cardiomyopathy: an update;European Heart Journal;2024-06-07

2. Pharmacological treatments for alcohol dependence: Evidence on uptake, inequalities and comparative effectiveness from a UK population‐based cohort;Drug and Alcohol Review;2024-04-23

3. Pharmacotherapy for Alcohol Use Disorder;JAMA;2023-11-07

4. A smartphone-based support system coupled with a bluetooth breathalyzer in the treatment of alcohol dependence: A 12-week randomized controlled trial;Internet Interventions;2023-09

5. Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis;Journal of Addiction Medicine;2022-11